The New Culture Club: UK NHS Goes Upstream For Care Delivery And Offers New Chances For Medtechs
Hopes are high for the NHS Long Term Plan’s ability to transform health-care delivery and make a potentially unsustainable service fit for the future. There are opportunities for diagnostics, devices and digital providers, but are the resources there to turn the Plan into a success story?
You may also be interested in...
NHS England’s Long Term Plan puts much emphasis on better use of diagnostic tools in health-care delivery. The UK medtech industry is now pressing for a strategy to ensure that these technologies are factored into all patient pathways. It says the data derived will be used to improve patient outcomes and system efficiency.
UK parliament’s indecision over how – or if – to enact Brexit saw the planned March 29 withdrawal deadline come and go. The default positions of the inter-ministerial Office for Lifesciences (OLS) and health-care products regulator (MHRA) are still to prepare for a no-deal exit from the EU.
The journey from medtech concept to implementation is long and slow, and new ideas often don’t make it all the way to manufacturing and approval. But when they do, what is needed is a system that guarantees adoption and usage of those proven, innovative solutions that clear the many hurdles en route to clinical practice.